Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1986 1
1987 2
1988 1
1990 3
1992 2
1993 2
1994 2
1995 2
1997 3
1998 4
1999 1
2003 4
2004 4
2005 1
2006 2
2007 2
2008 2
2009 1
2011 2
2012 3
2013 4
2014 1
2015 3
2016 4
2017 3
2018 1
2020 3
2021 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
LAIR-1 agonism as a therapy for acute myeloid leukemia.
Lovewell RR, Hong J, Kundu S, Fielder CM, Hu Q, Kim KW, Ramsey HE, Gorska AE, Fuller LS, Tian L, Kothari P, Paucarmayta A, Mason EF, Meza I, Manzanarez Y, Bosiacki J, Maloveste K, Mitchell N, Barbu EA, Morawski A, Maloveste S, Cusumano Z, Patel SJ, Savona MR, Langermann S, Myint H, Flies DB, Kim TK. Lovewell RR, et al. Among authors: myint h. J Clin Invest. 2023 Nov 15;133(22):e169519. doi: 10.1172/JCI169519. J Clin Invest. 2023. PMID: 37966113 Free PMC article.
Efficacy and safety of dihydroartemisinin-piperaquine.
Myint HY, Ashley EA, Day NP, Nosten F, White NJ. Myint HY, et al. Trans R Soc Trop Med Hyg. 2007 Sep;101(9):858-66. doi: 10.1016/j.trstmh.2007.05.018. Epub 2007 Jul 19. Trans R Soc Trop Med Hyg. 2007. PMID: 17659311 Review.
AmBisome: an overview of current use.
Myint H. Myint H. Hosp Med. 1999 Feb;60(2):123-6. doi: 10.12968/hosp.1999.60.2.1041. Hosp Med. 1999. PMID: 10320843 Review.
A systematic overview of published antimalarial drug trials.
Myint HY, Tipmanee P, Nosten F, Day NP, Pukrittayakamee S, Looareesuwan S, White NJ. Myint HY, et al. Trans R Soc Trop Med Hyg. 2004 Feb;98(2):73-81. doi: 10.1016/s0035-9203(03)00014-2. Trans R Soc Trop Med Hyg. 2004. PMID: 14964805 Review.
AIM Platform: A Novel Nano Artificial Antigen-Presenting Cell-Based Clinical System Designed to Consistently Produce Multi-Antigen-Specific T-Cell Products with Potent and Durable Anti-Tumor Properties.
Suarez L, Wang R, Carmer S, Bednarik D, Myint H, Jones K, Oelke M. Suarez L, et al. Among authors: myint h. Transfus Med Hemother. 2020 Dec;47(6):464-471. doi: 10.1159/000512788. Epub 2020 Nov 16. Transfus Med Hemother. 2020. PMID: 33442341 Free PMC article. Review.
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.
Aung TN, Gavrielatou N, Vathiotis IA, Fernandez AI, Shafi S, Yaghoobi V, Burela S, MacNeil T, Ahmed FS, Myint H, Flies DB, Langermann S, Rimm DL. Aung TN, et al. Among authors: myint h. Cancer Res Commun. 2023 Mar 21;3(3):471-482. doi: 10.1158/2767-9764.CRC-22-0334. eCollection 2023 Mar. Cancer Res Commun. 2023. PMID: 36960400 Free PMC article.
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden J, Schuening F, Myint H, Patel DD, Collier D, Heslop H, Krance R, Statkute L, Verda L, Traynor A, Kozak T, Hintzen RQ, Rose JW, Voltarelli J, Loh Y, Territo M, Cohen BA, Craig RM, Varga J, Barr WG. Burt RK, et al. Among authors: myint h. Arthritis Rheum. 2006 Dec;54(12):3750-60. doi: 10.1002/art.22256. Arthritis Rheum. 2006. PMID: 17133541 Free article. Review. No abstract available.
66 results